Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Lastest Finance News

CORRECT: Ocean Wilsons/Hansa merger hearing postponed for objection

23rd Sep 2025 12:12

(Correcting reference to expected index change) Read More

Octopus Renewables posts 2030 strategy and lower net asset value

23rd Sep 2025 12:00

(Alliance News) - Octopus Renewables Infrastructure Trust PLC on Tuesday announced the launch of its five-year strategy targeting substantial net asset value growth by 2030, as it posted an interim NAV fall. Read More

LONDON MARKET MIDDAY: Stocks up amid warnings on UK growth outlook

23rd Sep 2025 11:58

(Alliance News) - London stocks were higher around midday on Tuesday, amid warnings for a slowdown in UK economic growth next year and flash PMI readings underperforming against consensus estimates. Read More

Albion Technology first-half net asset value falls on write-downs

23rd Sep 2025 11:53

(Alliance News) - Albion Technology & General VCT PLC on Tuesday reported a dip in net asset value during the first half of 2025, as portfolio write-downs outweighed gains, though the venture capital trust said it continues to maintain a diversified portfolio of growth-focused businesses. Read More

IN BRIEF: Safestay interim revenue down amid challenging environment

23rd Sep 2025 11:34

Safestay PLC - London-based hostel operator - Announces swing to pretax profit of GBP591,000 in the first half of 2025, from a loss of GBP113,000 a year ago. Revenue falls 5.7% to GBP10.1 million from GBP10.7 million. Notably, Safestay reports other operating income of GBP1.2 million in the first half of 2025, compared to none a year prior. Cost of sales decreased to GBP1.5 million from GBP1.7 million, while administrative expenses increased to GBP7.8 million from GBP7.5 million. The company says during the first half it "delivered further strategic progress and a resilient financial performance, despite the challenging trading environment which impacted pricing and demand across the European hostels market." Read More

IN BRIEF: Quilter taps Alliance Witan deputy chair as board member

23rd Sep 2025 11:34

Quilter PLC - London-based wealth manager - Chooses Andrew Ross as non-executive director, with effect from January 1, 2026. Says Ross's appointment forms part of its "ongoing board succession planning". Ross joined the board of Witan Investment Trust PLC in 2019 and became its chair in 2020, serving in this role until its merger with Alliance Trust PLC in 2024. He is the deputy chair of the merged entity, Alliance Witan PLC, and he will step down from that role before to joining the Quilter board. Ross is also a non-executive director of Polar Capital Holdings PLC and Cadogan Settled Estates Ltd. Read More

Yu Group hails "resilient" interim trading; raises dividend 16%

23rd Sep 2025 11:34

(Alliance News) - Yu Group PLC on Tuesday reported the expansion of its forward contract book despite declines in wholesale energy prices, as it posted half-year revenue and profit gains. Read More

UPDATE: Ryanair to appeal EU order for France to claw back payments

23rd Sep 2025 11:27

(Alliance News) - Ryanair Holdings PLC on Tuesday said it will appeal an European Commission order for France to recover payments made to the budget carrier by Carcassonne airport in the far southwest of the country. Read More

IN BRIEF: Begbies Traynor immediately promotes Mark Fry to CEO

23rd Sep 2025 11:21

Begbies Traynor Group PLC - Manchester, England-based insolvency advisor - Promotes Mark Fry, executive director and head of restructuring and advisory services, to chief executive officer, effective immediately, which Begbies says is a newly created role on the group board. Fry joined Begbies in 2005 and led its restructuring and advisory division since 2010. "The group has grown significantly over the last ten years, in which time we have tripled the size of the business with a six-fold increase in adjusted profit before tax. As a result, the board has been considering the optimum leadership structure to reflect the current size of the group and its growth ambitions," Begbies says. Executive Chair Ric Traynor, who remains in his role, says: "Having significantly grown the group over the last ten years, now is the time to evolve and optimise our leadership structure. The changes being implemented will enable us to both manage the increased scale of the Begbies Traynor Group, whilst ensuring we have the right team in place to achieve our growth ambitions." Read More

AB Dynamics eyes to beat consensus for adjusted operating profit

23rd Sep 2025 11:17

(Alliance News) - AB Dynamics PLC on Tuesday announced "strong" trading in the first half of its financial year as underlying demand drivers remain strong. Read More

AIM WINNERS & LOSERS: Tap Global expects to post 30% revenue growth

23rd Sep 2025 11:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

FRP Advisory lifts first quarter dividend, confirms positive trading

23rd Sep 2025 11:03

(Alliance News) - FRP Advisory Group PLC on Tuesday said year-to-date trading has progressed in line with its expectations, as it provided un update ahead of its annual general meeting. Read More

Origin Enterprises highlights growth in Living Landscapes business

23rd Sep 2025 11:02

(Alliance News) - Origin Enterprises PLC on Tuesday raised its dividend, as it reported a double-digit-percentage rise in annual earnings. Read More

IN BRIEF: RTW Biotech lifts NAV on Biogen's USD85 million Alcyone deal

23rd Sep 2025 11:01

RTW Biotech Opportunities Ltd - Guernsey, Channel Islands-based investor in high-growth life science sectors - Notes Biogen Inc's agreement announced last Thursday to acquire portfolio company Alcyone Therapeutics Inc for USD85 million upfront plus milestone payments. Says the deal represents a 242% uplift on RTW's USD2.1 million carrying value of Alcyone, adding USD5.0 million, or around 0.7%, to its August 31 NAV, where Alcyone represented approximately a 0.3% position. Alcyone is developing ThecaFlex DRx, an implantable device for intrathecal delivery of neurological therapies, which Biogen plans to deploy with its marketed drug Spinraza, with a launch targeted in 2028. The transaction its RTW's second portfolio takeout this year, following Merck & Co Inc's purchase of Verona Pharma PLC, and says it highlights embedded value in its private holdings. Read More

Oxford BioMedica narrows interim loss, backs annual outlook

23rd Sep 2025 10:48

(Alliance News) - Oxford BioMedica PLC on Tuesday hailed its "strong revenue pipeline" and growth visibility, as it kept its financial outlook for the full-year unaltered. Read More

FTSE 100 Latest
Value9,424.75
Change-28.02